We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.8B
AUM Growth
-$421M
(-8.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-11.33%
Top 10 Holdings %
Top 10 Hldgs %
11.23%
Holding
2,126
New
460
Increased
575
Reduced
566
Closed
461
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CA
CA, Inc.
CA
|
+$70.9M |
| 2 |
Alibaba
BABA
|
+$31.2M |
| 3 |
GTYH
GTY Technology Holdings, Inc. Common Stock
GTYH
|
+$26.6M |
| 4 |
GE Aerospace
GE
|
+$25.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAVM
Cavium, Inc.
CAVM
|
+$166M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$96.1M |
| 3 |
NXP Semiconductors
NXPI
|
+$85.7M |
| 4 |
XL
XL Group Ltd.
XL
|
+$75.4M |
| 5 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$57.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.81% |
| 2 | Consumer Discretionary | 14.52% |
| 3 | Healthcare | 12.46% |
| 4 | Industrials | 12.28% |
| 5 | Financials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Aquestive Therapeutics
AQST
$494M
| $816K | 0.02% |
+46,923
| New | +$773K |
|
1102
Shenandoah Telecom
SHEN
$746M
| $815K | 0.02% |
+21,171
| New | +$754K |
|
|
GPX
1103
DELISTED
GP Strategies Corp.
GPX
| $813K | 0.02% |
48,551
+8,834
| +22% | +$163K |
|
1104
Toll Brothers
TOL
$14.5B
| $812K | 0.02% |
+24,337
| New | +$881K |
|
|
OLBK
1105
DELISTED
Old Line Bancshares, Inc.
OLBK
| $812K | 0.02% |
25,554
-20,231
| -44% | -$693K |
|
1106
Reliance Steel & Aluminium
RS
$21.6B
| $811K | 0.02% |
9,521
-1,788
| -16% | -$158K |
|
|
LUMO
1107
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $805K | 0.02% |
36,087
+26,309
| +269% | +$800K |
|
|
OLP
1108
One Liberty Properties
OLP
$527M
| $802K | 0.02% |
29,938
+9,950
| +50% | +$277K |
|
|
SBT
1109
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $801K | 0.02% |
71,115
+19,313
| +37% | +$242K |
|
1110
Ingevity
NGVT
$2.68B
| $799K | 0.02% |
7,846
-2,067
| -21% | -$200K |
|
|
CIT
1111
DELISTED
CIT Group Inc.
CIT
| $799K | 0.02% |
15,455
-28,185
| -65% | -$1.5M |
|
1112
Old Second Bancorp
OSBC
$1.29B
| $797K | 0.02% |
51,721
-60,623
| -54% | -$924K |
|
1113
CNO Financial Group
CNO
$5.1B
| $796K | 0.02% |
37,559
-12,850
| -25% | -$270K |
|
|
KIN
1114
DELISTED
Kindred Biosciences, Inc.
KIN
| $796K | 0.02% |
57,633
+45,650
| +381% | +$618K |
|
1115
FS Bancorp
FSBW
$320M
| $795K | 0.02% |
28,542
-1,164
| -4% | -$34.8K |
|
1116
Macerich
MAC
$6.92B
| $793K | 0.02% |
+14,406
| New | +$830K |
|
1117
CNA Financial
CNA
$14.1B
| $792K | 0.02% |
17,401
+3,561
| +26% | +$165K |
|
|
DRRX
1118
DELISTED
DURECT Corp
DRRX
| $790K | 0.02% |
70,493
-32,427
| -32% | -$441K |
|
|
TBI
1119
Trueblue
TBI
$311M
| $789K | 0.02% |
30,292
+5,236
| +21% | +$145K |
|
1120
ResMed
RMD
$30.7B
| $779K | 0.02% |
6,802
-9,036
| -57% | -$990K |
|
1121
Tandem Diabetes Care
TNDM
$1.56B
| $779K | 0.02% |
+18,362
| New | +$641K |
|
|
ACOR
1122
DELISTED
Acorda Therapeutics
ACOR
| $779K | 0.02% |
331
-330
| -50% | -$1.02M |
|
1123
BP
BP
$107B
| $777K | 0.02% |
17,513
-111,672
| -86% | -$4.67M |
|
1124
Southern Copper
SCCO
$166B
| $776K | 0.02% |
+19,338
| New | +$795K |
|
|
CTT
1125
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $776K | 0.02% |
67,940
-87,116
| -56% | -$1.07M |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Oxford Asset Management held 2,126 positions worth $4.8B, down 8.1% from $5.22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Oxford Asset Management withdrew a net $543M in Q3 2018, closing 461 positions and reducing 566 holdings. Its most notable exit was Cavium, Inc., an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Oxford Asset Management opened a new position in CA, Inc. worth $72.4M.
- Oxford Asset Management's largest Q3 2018 buy was CA, Inc.: 1,645,180 shares worth $72.4M.
- Oxford Asset Management added most to GTY Technology Holdings, Inc. Common Stock in Q3 2018, an estimated $26.6M increase.
- Oxford Asset Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $85.7M.
- Oxford Asset Management fully exited Cavium, Inc. in Q3 2018, selling an estimated $166M.
- Oxford Asset Management's ten largest holdings make up 11% of its $4.8B portfolio in Q3 2018.
- Oxford Asset Management opened 460 new positions and closed 461 in Q3 2018.
- Oxford Asset Management's portfolio value fell 8.1% quarter-over-quarter to $4.8B.
Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.